GSK-1674330A

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameGSK-1674330A

Drug Alias NameTetravalent HPV L1 16/18/33/58 virus-like particle vaccine - GlaxoSmithKlineHuman papillomavirus quadrivalent (types 16, 18, 33, 58) recombinant vaccine - GlaxoSmithKlineHuman papillomavirus (types 16, 18, 33, 58) L1 virus-like particle vaccine - GlaxoSmithKlineHPV-16/18/33/58 tetravalent vaccineHuman papillomavirus (types 16, 18, 33, 58) L1 VLP vaccine - GlaxoSmithKline

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A